Loading…
Academic Journal
INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS
Zh. M. Sizova
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 2, Pp 183-187 (2015)
Saved in:
| Title | INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS |
|---|---|
| Authors | Zh. M. Sizova |
| Publication Year |
2015
|
| Source |
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 2, Pp 183-187 (2015)
|
| Description |
Indications for myocardial cytoprotector, trimetazidine, in patients with ischemic heart disease are analyzed and justified according to evidence based medicine. Results of a multicenter randomized comparative KARDIOKANON study are discussed in terms of efficacy and tolerability of two variants of the complex 12-week treatment in patients with angina II-III functional class, based on the original and generic drugs. The study showed clinical equivalence of the generic DeprenormR (Canonpharma Production) to the original trimetazidine.
|
| Document Type |
article
|
| Language |
English
Russian |
| Publisher Information |
Столичная издательская компания, 2015.
|
| Subject Terms | |
